3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Lung Neoplasms
9
Carcinoma, Non-Small-Cell Lung
7
Pleural Effusion, Malignant
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Limited Stage Small Cell Lung Cancer
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fatigue
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cachexia
1
Brain Neoplasms
1
Interventions
pembrolizumab
30
Carboplatin
13
Trastuzumab
8
Paclitaxel
7
Nivolumab
7
Cisplatin
6
Ipilimumab
5
Cetuximab
5
Bevacizumab
5
Taxes
4
Pemetrexed
4
Specimen Handling
3
Irinotecan
3
Docetaxel
3
Cyclophosphamide
3
Biopsy
3
tisotumab vedotin
2
temsirolimus
2
spartalizumab
2
sargramostim
2
pertuzumab
2
lenvatinib
2
fludarabine
2
epacadostat
2
enzalutamide
2
aldesleukin
2
X-Rays
2
Ritonavir
2
Psychiatric Rehabilitation
2
Oxaliplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Sodium Chloride
×
Thoracic
×
Clear all
NCT04237090
2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3
Completed
27 enrolled